A detailed history of Parthenon LLC transactions in Amgen Inc stock. As of the latest transaction made, Parthenon LLC holds 1,177 shares of AMGN stock, worth $328,100. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,177
Previous 1,177 -0.0%
Holding current value
$328,100
Previous $367,000 3.27%
% of portfolio
0.05%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$255.7 - $288.46 $12,785 - $14,422
-50 Reduced 4.07%
1,177 $338,000
Q2 2023

Jul 26, 2023

BUY
$214.27 - $253.37 $10,713 - $12,668
50 Added 4.25%
1,227 $272,000
Q3 2021

Oct 28, 2021

SELL
$212.27 - $248.7 $47,548 - $55,708
-224 Reduced 15.99%
1,177 $250,000
Q2 2021

Jul 28, 2021

BUY
$233.58 - $259.14 $52,321 - $58,047
224 Added 19.03%
1,401 $341,000
Q1 2021

Apr 23, 2021

SELL
$221.91 - $258.6 $7,766 - $9,051
-35 Reduced 2.89%
1,177 $293,000
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $281,726 - $335,486
-1,302 Reduced 51.79%
1,212 $279,000
Q3 2020

Oct 29, 2020

BUY
$234.65 - $260.95 $293,312 - $326,187
1,250 Added 98.89%
2,514 $639,000
Q1 2020

Apr 28, 2020

SELL
$182.24 - $241.7 $10,752 - $14,260
-59 Reduced 4.46%
1,264 $256,000
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $6,964 - $8,344
-40 Reduced 2.93%
1,323 $256,000
Q1 2019

May 03, 2019

SELL
$180.87 - $203.88 $1,085 - $1,223
-6 Reduced 0.44%
1,363 $259,000
Q4 2018

Jan 29, 2019

BUY
$178.4 - $208.25 $11,596 - $13,536
65 Added 4.98%
1,369 $267,000
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $14,823 - $16,711
-80 Reduced 5.78%
1,304 $270,000
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $30,497 - $35,640
-180 Reduced 11.51%
1,384 $236,000
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $99,248 - $110,890
-588 Reduced 27.32%
1,564 $272,000
Q3 2017

Oct 31, 2017

BUY
$167.29 - $191.0 $360,008 - $411,032
2,152
2,152 $401,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Parthenon LLC Portfolio

Follow Parthenon LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parthenon LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parthenon LLC with notifications on news.